Glucagon-like peptide-1 receptor agonists as an effective therapeutic agent for diabetes mellitus and obesity in patients with schizophrenia under treatment with second-generation antipsychotics
- Publication date
- 21 December 2020
- Publisher
- Nagasaki University School of Medicine